Clare Nolan is a co-founder of The Recognition Academy, a training company that helps physicians and the pharmaceutical industry work together. She has over 20 years’ experience in drug development and brand commercialisation within academia and the pharmaceutical industry.
After obtaining a degree in pharmacy and a PhD in prostate cancer drug development from Cardiff School of Pharmacy and Medicine, UK (sponsored by the Cancer Research Campaign), Clare worked at Eli Lilly & Company and Lilly Research in neuroscience product development, clinical trial design and sales. As a Regulatory Manager at GSK, she led European license submissions for new cardiovascular products and in-licensing agreements in respiratory products. At Strategic Consultants International, she led clinical development advisory boards and continuing medical education programmes throughout Europe, the USA and Asia. At AstraZeneca, she was responsible for global publications and communications from early pipeline and prelaunch to postlaunch for products in oncology, urology, immunology and cardiovascular and infectious diseases. On behalf of academia and industry, she has established global opinion leader networks, profile management tools and company-wide opinion leader relationship management systems. Clare has trained global cross-functional teams on publications issues and challenges, internal policies and external guidelines. Most recently, as Director of Professional Development with Lionsden Communications, she has trained opinion leaders and emerging leaders in spoken communication, to their peers. She is a member of ISMPP.
As a Director at The Recognition Academy, Clare trains physicians on how to partner with the pharma industry so they can gain recognition for their contribution to medicine with enhanced reputation and credibility. The Academy also trains industry professionals to partner effectively and ethically with physicians, enabling them to advance patient care whilst upholding their reputation.